MCM
AMED

MV Capital Management’s Amedisys AMED Stock Holding History

MV Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-7
Closed -$689 – 1073
2025
Q2 		$689 Sell
7
-1
-13% -$95 ﹤0.01% 814
2025
Q1 		$742 Buy
8
+2
+33% +$184 ﹤0.01% 785
2024
Q4 		$545 Buy
6
+3
+100% +$276 ﹤0.01% 803
2024
Q3 		$290 Hold
3
– – ﹤0.01% 865
2024
Q2 		$276 Buy
+3
New +$278 ﹤0.01% 774

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

MV Capital Management's AMED Position: Q3 2025 in Review

MV Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 7 shares — an estimated $689 sold.

MV Capital Management first reported a position in AMED in Q2 2024 and held it in 5 quarters. The position peaked at $742 in Q1 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • MV Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • MV Capital Management sold 7 Amedisys shares in Q3 2025, an estimated $689.
  • MV Capital Management first reported a position in Amedisys in Q2 2024 and held it in 5 quarters.
  • MV Capital Management's Amedisys position peaked at $742 in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on MV Capital Management's 13F filing for Q3 2025, filed 23 Feb 2026.